Natural Hair rogaine, rogaine, regain, topical minoxidil, MINOXIDIL, regaine 5% extra strength Natural-Hair - Alopecia and Hair loss resource center. - Topical minoxidil information and online ordering

Natural HairFrequently Asked Questions
Links to other SitesPrivacy Policy

Search ....  

UK SITE
View your shopping cart

Dutas
Propecia
Proscar
Regaine 5%
Headway
Nizoral Shampoo
Prostaguard
Retin-A
Skinoren
Pill Cutter


Hairloss information and resources
provided
by Natural-Hair

Hair Structure and Life Cycle
Common Types of Hair Loss
Alopecia Areata
Androgenetic Alopecia
Anagen Effluvium
Self Induced Hair Loss
Scarring Alopecia
Other Types of Hair Loss
Hair Loss Treatments
Medical Treatments for Androgenetic Alopecia
Natural Treatments for Androgenetic Alopecia
Alopecia Areata Treatments
Glossary of terms
Links to other sites
E-mail Enquiries/ Comments
        
Home Inhouse Drugstore
 
 
  Topical minoxidil solution (1% and 5%) ...

TITLE
Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata.

AUTHOR
Fiedler-Weiss VC

SOURCE
J Am Acad Dermatol 1987 Mar; 16 (3 Pt 2): 745-8

LANGUAGE OF ORIGIN
English

ABSTRACT
Topical minoxidil solution can induce hair regrowth in alopecia areata. A dose-response effect was demonstrated when 48 patients treated with topical 1% minoxidil were compared with 47 patients treated with topical 5% minoxidil. A total of 66 patients were enrolled, 26 of them participating in both study groups. Patients with extensive (75% or greater) scalp hair loss showed a response rate of 38%, defined as terminal hair regrowth, with 1% minoxidil versus an 81% response rate with 5% minoxidil. The current 2% formulation is most likely to elicit cosmetically acceptable regrowth in those with patchy alopecia areata. Occlusion of the treated area appears to be necessary to achieve and maintain maximum results. Nonresponders are most likely to be found among those with the most extensive scalp hair loss. No other clinical features correlate with response to treatment. However, a finding of increased T cell blastogenesis before treatment may predict response. In patients with severe alopecia areata, hair loss generally recurs after treatment is stopped and may recur during treatment. Systemic absorption of topically applied and occluded minoxidil solutions (1% and 5%) was minimal; no clinically significant changes in blood pressure, weight, cardiovascular status, electrocardiogram, electrolytes, complete blood count, or urinalysis were seen. Mild local irritation occurred, and two of the 66 patients developed allergic contact dermatitis to minoxidil, as confirmed by patch tests. (AUTHOR)

MJTR: Alopecia Areata DT. Minoxidil TU.

MNTR: Administration, Topical. Clinical Trials. Comparative Study. Dose-Response Relationship, Drug. Double-Blind Method. Human. CLINICAL TRIAL. CONTROLLED CLINICAL TRIAL. JOURNAL ARTICLE

RNUM: 38304-91-5 (Minoxidil)

GEOT: UNITED STATES

IDEN: ISSN: 0190-9622. JOURNAL-CODE: HVG. ENTRY-DATE: 870429. JOURNAL-SUBSET: M. IM-DATE: 8707.

ACCE: 87166921